3 Stocks I Saw on T...
Health Care: Drugs
Cubist Pharmaceuticals Inc. (CBST: NASDAQ)
$39.93 0.26 | 0.66%
06/04/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 33.02M | 94.32M | 79.60M | 169.82M |
| Operating Gains/Losses | 0.00 | 15.94M | 1.17M | -1.98M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -21.97M | -3.37M | -14.66M | -14.09M |
| (Increase) Decrease in Inventories | -10.00M | 1.53M | -3.47M | -3.22M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 51.34M | 6.25M | 21.36M | 24.34M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 15.15M | -6.76M | -2.61M | 4.25M |
| Other Non-Cash Items | 94.40M | 14.42M | 19.82M | 65.92M |
| Net Cash From Continuing Operations | 200.37M | 184.47M | 160.58M | 122.19M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 200.37M | 184.47M | 160.58M | 122.19M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -100.07M | -17.47M | -11.11M | -25.34M |
| Acquisitions | -200.66M | 0.00 | -92.18M | -10.19M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -439.54M | -222.70M | -417.03M | -35.53M |
| Issuance of Debt | 0.00 | 259.22M | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 61.56M | 16.33M | 4.74M | 14.42M |
| Repayment of Long-Term Debt | -16.79M | 0.00 | 0.00 | -46.84M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 18.08M | -22.56M | 235.00K | 0.00 |
| Net Cash From Financing Activities | 62.84M | 252.99M | 4.98M | -32.42M |
| Effect of Exchange Rate Changes | 985.00K | 890.00K | -234.00K | -6.00K |
| Net Change in Cash & Cash Equivalents | -175.35M | 215.65M | -251.71M | 54.24M |
Portfolios with CBST
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 6
- ContributorStocks At New 52-Week Highs...
- ContributorTop-Rated Biotechnology Stocks
- ContributorEarnings Short Squeeze Play...
- ContributorStocks At New 52-Week Highs...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ProJoel Greenblatt - Gotham Ca...
- ContributorEarnings Short Squeeze Play...
Latest CBST Headlines from TheStreet
- Upgrades Roundup: TXT, CBST, BK, MCP, AVP, LFL, SHO, BPI 04.23.12 | 06:04 am
- Cubist Pharmaceuticals Inc. Stock Upgraded (CBST) 04.20.12 | 05:04 am
- 5 Stocks Poised to Pop on Earnings 04.18.12 | 07:04 am
- Cubist Stock Hits New 52-Week High (CBST) 03.26.12 | 11:03 am
- Cubist Stock Hits New 52-Week High (CBST) 03.09.12 | 10:03 am
- Cubist Reaches New 52-Week High (CBST) 02.22.12 | 03:02 pm
- Cubist Stock Hits New 52-Week High (CBST) 02.03.12 | 10:02 am
- TheStreet Ratings Top 10 Rating Changes 01.23.12 | 12:01 pm
- Cubist Pharmaceuticals Inc. Stock Downgraded (CBST) 01.23.12 | 05:01 am
- 5 Stocks Set to Soar on Bullish Earnings 01.18.12 | 03:01 pm
Press Releases for CBST
- Cubist Pharmaceuticals Marks 20th Anniversary By Making Its Largest-Ever Commitment To STEM Programs - Business Wire 05.16.12 | 09:05 am
- Cubist Pharmaceuticals To Present At May Investor Conference - Business Wire 05.07.12 | 10:05 am
- Cubist Announces Positive Results From ENTEREG® Phase 4 Study In Patients Undergoing Radical Cystectomy - Business Wire 04.17.12 | 05:04 pm
- Cubist Pharmaceuticals To Announce Q112 Financial Results On Wednesday, April 18th, 2012 - Business Wire 04.02.12 | 10:04 am
- Senator Scott Brown And Cubist Pharmaceutical President And CEO Michael Bonney (right) And Steven Gilman, Executive Vice President, Research & Development And Chief Scientific Officer. - Business Wire 03.16.12 | 12:03 pm
- Cubist Pharmaceuticals Appoints Jane Henney To Board Of Directors - Business Wire 03.09.12 | 08:03 am
- Cubist Pharmaceuticals To Present At February/March Investor Conferences - Business Wire 02.20.12 | 11:02 am
- Cubist Pharmaceuticals Appoints Alison Lawton To Board Of Directors - Business Wire 02.16.12 | 08:02 am
- Cubist Receives CUBICIN Paragraph IV Notice Letter - Business Wire 02.09.12 | 07:02 am
- Cubist Pharmaceuticals Reports 2011 Fourth Quarter And Full Year Financial Results - Business Wire 01.19.12 | 04:01 pm
Partner Headlines for CBST
- After Hours Most Active for Jun 1, 2012 : BAC, QQQ, MSFT, JPM, KITD, SWK, WFC, WMB, MET, STX, CBST, INTC - NASDAQ 06.01.12 | 08:06 pm
- The Definitive Biotech ETF Guide (IBB, XBI, FBT) - Benzinga 05.21.12 | 01:05 pm
- Medical Stocks Forming Bases Amid Market Sell-Off - Investor's Business Daily 05.18.12 | 06:05 pm
- Big Pharma Abandons Antibiotics: An Opening For Small Biotech - Seeking Alpha 05.13.12 | 09:05 am
- 2 Low-Growth Pharma Behemoths: Merck, J&J - Seeking Alpha 05.01.12 | 09:05 am
- Kinetics Hedge Fund's Top Undervalued Picks - Seeking Alpha 03.23.12 | 05:03 pm
- Alnylam Delivers In-Line Numbers - Analyst Blog - Zacks 02.13.12 | 10:02 am
- 10 Stocks That Made New Highs On Friday: Hedging Costs - Seeking Alpha 01.15.12 | 07:01 am
- Cubist's Preliminary Sales Impress - Analyst Blog - Zacks 01.11.12 | 10:01 am
- Alnylam States Preclinical Data - Analyst Blog - Zacks 12.30.11 | 04:12 pm
